Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada; Michael Cuccione Childhood Cancer Research Program, BC Children's Hospital, Vancouver, Canada.
Central Institute for Engineering, Electronics and Analytics, ZEA-3, Forschungszentrum Jülich, Germany.
Mol Cell Proteomics. 2019 Nov;18(11):2335-2347. doi: 10.1074/mcp.TIR119.001560. Epub 2019 Aug 30.
Protein N termini unambiguously identify truncated, alternatively translated or modified proteoforms with distinct functions and reveal perturbations in disease. Selective enrichment of N-terminal peptides is necessary to achieve proteome-wide coverage for unbiased identification of site-specific regulatory proteolytic processing and protease substrates. However, many proteolytic processes are strictly confined in time and space and therefore can only be analyzed in minute samples that provide insufficient starting material for current enrichment protocols. Here we present High-efficiency Undecanal-based N Termini EnRichment (HUNTER), a robust, sensitive and scalable method for the analysis of previously inaccessible microscale samples. HUNTER achieved identification of >1000 N termini from as little as 2 μg raw HeLa cell lysate. Broad applicability is demonstrated by the first N-terminome analysis of sorted human primary immune cells and enriched mitochondrial fractions from pediatric cancer patients, as well as protease substrate identification from individual wild type and Vacuolar Processing Enzyme-deficient mutant seedlings. We further implemented the workflow on a liquid handling system and demonstrate the feasibility of clinical degradomics by automated processing of liquid biopsies from pediatric cancer patients.
蛋白质 N 末端可明确鉴定出具有不同功能的截断、选择性翻译或修饰的蛋白异构体,并揭示疾病中的扰动。选择性富集 N 端肽对于实现对特定调节蛋白水解加工和蛋白酶底物的无偏鉴定的蛋白质组范围的覆盖是必要的。然而,许多蛋白水解过程在时间和空间上受到严格限制,因此只能在提供用于当前富集方案的起始材料不足的微小样本中进行分析。在这里,我们提出了基于高效十一醛的 N 末端富集(HUNTER),这是一种用于分析以前无法获取的微样本的强大、敏感和可扩展的方法。HUNTER 从低至 2 μg 的原始 HeLa 细胞裂解物中鉴定出了 >1000 个 N 末端。通过对分选的人类原代免疫细胞和儿科癌症患者富集的线粒体部分进行的首次 N 端组学分析,以及对单个野生型和液泡加工酶缺陷型突变体幼苗中的蛋白酶底物鉴定,证明了其广泛的适用性。我们进一步在液体处理系统上实现了该工作流程,并通过对儿科癌症患者的液体活检进行自动化处理,展示了临床降解组学的可行性。